Frequency Therapeutics, Inc.

Frequency Therapeutics, Inc.verified

FREQ

Price:

$0.2996

Market Cap:

$10.94M

Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules and activate progenitor cells within the body to create functional tissue. The company's lead product candidate is FX-322, which is in Phase IIa clinical trial to treat the underlying cause of sensorineural hearing loss. It is also developing medicines for patients across a range of degenerative conditions, including multiple sclerosis, and diseases of the muscle, gastrointestinal tract, skin, and bone. The company has a license and collaboration agreement...[Read more]

Industry

Biotechnology

IPO Date

2019-10-03

Stock Exchange

NASDAQ

Ticker

FREQ

The Enterprise Value as of November 2024 (TTM) for Frequency Therapeutics, Inc. (FREQ) is -29354368.00

According to Frequency Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -29354368.00. This represents a change of -235.98% compared to the average of 21.59M of the last 4 quarters.

Frequency Therapeutics, Inc. (FREQ) Historical Enterprise Value (quarterly & annually)

How has FREQ Enterprise Value performed in the past?

The mean historical Enterprise Value of Frequency Therapeutics, Inc. over the last ten years is 200.66M. The current -29354368.00 Enterprise Value has changed -1562.93% with respect to the historical average. Over the past ten years (40 quarters), FREQ's Enterprise Value was at its highest in in the December 2020 quarter at 1.02B. The Enterprise Value was at its lowest in in the September 2023 quarter at -26634772.68.

Quarterly (TTM)
Annual

Average

200.66M

Median

123.04M

Minimum

-65733735.15

Maximum

962.90M

Frequency Therapeutics, Inc. (FREQ) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Frequency Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual Enterprise Value = 962.90M

Minimum Annual Increase = -1564.85%

Minimum Annual Enterprise Value = -65733735.15

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20230-100.00%
202294.89M-33.26%
2021142.19M-85.23%
2020962.90M-1564.85%
2019-65733735.15-153.42%
2018123.04M-16.46%

Frequency Therapeutics, Inc. (FREQ) Average Enterprise Value

How has FREQ Enterprise Value performed in the past?

The current Enterprise Value of Frequency Therapeutics, Inc. (FREQ) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

79.03M

5-year avg

226.85M

10-year avg

200.66M

Frequency Therapeutics, Inc. (FREQ) Enterprise Value vs. Peers

How is FREQ’s Enterprise Value compared to its peers?

Frequency Therapeutics, Inc.’s Enterprise Value is less than Lineage Cell Therapeutics, Inc. (70.15M), less than MAIA Biotechnology, Inc. (41.04M), less than Armata Pharmaceuticals, Inc. (138.55M), less than Portage Biotech Inc. (1.55M), less than PMV Pharmaceuticals, Inc. (47.77M), less than Olema Pharmaceuticals, Inc. (468.89M), less than Enochian Biosciences, Inc. (85.97M), less than Scholar Rock Holding Corporation (2.79B), less than Passage Bio, Inc. (24.72M), less than Shattuck Labs, Inc. (6.89M), less than C4 Therapeutics, Inc. (307.45M), less than Eliem Therapeutics, Inc. (119.64M), less than Prelude Therapeutics Incorporated (59.21M), less than Monte Rosa Therapeutics, Inc. (439.72M), less than Absci Corporation (0), less than Adverum Biotechnologies, Inc. (267.83M), less than Kezar Life Sciences, Inc. (106.06M), less than Oncternal Therapeutics, Inc. (36.78M), less than null (-9513999.00),

Build a custom stock screener for Frequency Therapeutics, Inc. (FREQ) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Frequency Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Frequency Therapeutics, Inc. (FREQ) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Frequency Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Frequency Therapeutics, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Frequency Therapeutics, Inc. (FREQ)?

What is the 3-year average Enterprise Value for Frequency Therapeutics, Inc. (FREQ)?

What is the 5-year average Enterprise Value for Frequency Therapeutics, Inc. (FREQ)?

How does the current Enterprise Value for Frequency Therapeutics, Inc. (FREQ) compare to its historical average?